Cargando…
Discovery of pancreastatin inhibitor PSTi8 for the treatment of insulin resistance and diabetes: studies in rodent models of diabetes mellitus
Pancreastatin (PST) is an endogenous peptide which regulates glucose and lipid metabolism in liver and adipose tissues. In type 2 diabetic patients, PST level is high and plays a crucial role in the negative regulation of insulin sensitivity. Novel therapeutic agents are needed to treat the diabetes...
Autores principales: | Hossain, Zakir, Valicherla, Guru R., Gupta, Anand P., Syed, Anees A., Riyazuddin, Mohammed, Chandra, Sharat, Siddiqi, Mohammad I., Gayen, Jiaur R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992141/ https://www.ncbi.nlm.nih.gov/pubmed/29880906 http://dx.doi.org/10.1038/s41598-018-27018-8 |
Ejemplares similares
-
Evaluation of the Pharmacokinetics of the Pancreastatin Inhibitor PSTi8 Peptide in Rats: Integration of In Vitro and In Vivo Findings
por: Valicherla, Guru R., et al.
Publicado: (2022) -
Combination of Pancreastatin inhibitor PSTi8 with metformin inhibits Fetuin-A in type 2 diabetic mice
por: Singh, Pragati, et al.
Publicado: (2020) -
PSTi8 with metformin ameliorates perimenopause induced steatohepatitis associated ER stress by regulating SIRT-1/SREBP-1c axis
por: Singh, Pragati, et al.
Publicado: (2020) -
Discovery of a Novel Target for the Dysglycemic Chromogranin A Fragment Pancreastatin: Interaction with the Chaperone GRP78 to Influence Metabolism
por: Biswas, Nilima, et al.
Publicado: (2014) -
Formulation optimization of Docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity
por: Valicherla, Guru R., et al.
Publicado: (2016)